99 results in Exploration of Musculoskeletal Diseases
Latest
Sort by :
- Latest
- Most Viewed
- Most Downloaded
- Most Cited
Open Access
Review
Calcium pyrophosphate deposition (CPPD) disease: a review of pathophysiology, clinic and diagnosis
Gamze Dilek ... Kemal Nas
Published: August 11, 2025 Explor Musculoskeletal Dis. 2025;3:100799
This article belongs to the special issue Calcium Pyrophosphate Deposition Disease
Open Access
Review
Biologics and biosimilars in musculoskeletal diseases: addressing regulatory inconsistencies and clinical uncertainty
Lauren N. McGrath ... Steven R. Feldman
Published: July 21, 2025 Explor Musculoskeletal Dis. 2025;3:100798
This article belongs to the special issue Biosimilars: State of the Art in the Treatment of Rheumatic Diseases
Open Access
Review
Risk factors of neoplastic disease in patients with systemic rheumatic disorders
Eugeniusz J. Kucharz
Published: July 16, 2025 Explor Musculoskeletal Dis. 2025;3:100797
Open Access
Correction
Correction: The ‘FebBenz’ approach for severe difficult-to-treat gout
Enrique Calvo-Aranda ... Marta Novella-Navarro
Published: July 07, 2025 Explor Musculoskeletal Dis. 2025;3:100796
Open Access
Review
A survey of the composition, safety, efficacy and regulation of non-autologous biologic treatments in human musculoskeletal pathologies
Theodore Sand
Published: June 25, 2025 Explor Musculoskeletal Dis. 2025;3:100795
This article belongs to the special issue Innovation in Orthopedics
Open Access
Systematic Review
Quality approaches and standards of 3D printing in orthopedic and traumatological settings: a systematic review
Tanja Neussl ... Johannes Dominikus Pallua
Published: June 16, 2025 Explor Musculoskeletal Dis. 2025;3:100794
This article belongs to the special issue Innovation in Orthopedics
Open Access
Original Article
The ‘FebBenz’ approach for severe difficult-to-treat gout
Enrique Calvo-Aranda ... Marta Novella-Navarro
Published: May 22, 2025 Explor Musculoskeletal Dis. 2025;3:100793
This article belongs to the special issue Pharmacological and Non-Pharmacological Management of Gout
Open Access
Review
Perspectives on minimally invasive treatments using magnetically labeled bone marrow mesenchymal stem cells
Shinobu Yanada
Published: May 21, 2025 Explor Musculoskeletal Dis. 2025;3:100792
This article belongs to the special issue Cell Therapy and Tissue Engineering for Musculoskeletal Conditions: From Pre-clinical Studies to Clinical Trials
Open Access
Review
Management of gout in advanced renal disease
John S. Richards ... Mohan Ramkumar
Published: May 07, 2025 Explor Musculoskeletal Dis. 2025;3:100791
This article belongs to the special issue Evaluation and Outcomes in the Management of Gout
Open Access
Perspective
Can fracture non-union be predicted using deep learning?
Ali Yüce ... Abdülhamit Misir
Published: April 08, 2025 Explor Musculoskeletal Dis. 2025;3:100790
This article belongs to the special issue Innovation in Orthopedics
Open Access
Original Article
The prevalence and risk factors of gouty arthritis among fishermen in the Niger Delta region of Nigeria
Gogo James Owo ... Enyohwo Dennis Kpomah
Published: March 25, 2025 Explor Musculoskeletal Dis. 2025;3:100789
Open Access
Review
Urate lowering therapy in primary care: rheum for improvement
Emilie Schurenberg ... Kenneth G. Saag
Published: March 25, 2025 Explor Musculoskeletal Dis. 2025;3:100788
This article belongs to the special issue Pharmacological and Non-Pharmacological Management of Gout
Open Access
Commentary
Highly effective treatment options for rheumatoid arthritis afforded by the availability of biosimilars
Leticia A. Shea, Jamshaid S. Ahmed
Published: March 03, 2025 Explor Musculoskeletal Dis. 2025;3:100787
This article belongs to the special issue Biosimilars: State of the Art in the Treatment of Rheumatic Diseases
Open Access
Commentary
Re-conceptualizing structural damage in chronic calcium pyrophosphate crystal inflammatory arthritis through ultrasonography: a pictorial essay
Janeth Yinh ... Ali Guermazi
Published: February 24, 2025 Explor Musculoskeletal Dis. 2025;3:100786
This article belongs to the special issue Multifaceted Imaging in Rheumatic and Musculoskeletal Diseases
Open Access
Perspective
Perspective on clinical and imaging tools for early identification of temporomandibular joint involvement in juvenile idiopathic arthritis
Silvia Magni-Manzoni
Published: February 11, 2025 Explor Musculoskeletal Dis. 2025;3:100785
This article belongs to the special issue Multifaceted Imaging in Rheumatic and Musculoskeletal Diseases
Open Access
Short Communication
Transition from reference adalimumab to biosimilar SB5 in patients with rheumatoid arthritis: sub-analysis of Spanish patients in the PROPER study
Fernando Pérez-Ruiz ... Eugenio Chamizo Carmona
Published: February 10, 2025 Explor Musculoskeletal Dis. 2025;3:100784
This article belongs to the special issue Biosimilars: State of the Art in the Treatment of Rheumatic Diseases
Open Access
Original Article
Efficacy of switching from originator adalimumab to biosimilar adalimumab-AACF in patients with axial spondyloarthritis: a 12-month observational study
Fanny Alcira Reyes Neira ... Andrea Yukie Shimabuco
Published: February 10, 2025 Explor Musculoskeletal Dis. 2025;3:100783
This article belongs to the special issue Biosimilars: State of the Art in the Treatment of Rheumatic Diseases
Open Access
Review
Optimizing development of anti-TNFα biosimilars based on 10 years’ experience
Cecil Nick
Published: February 08, 2025 Explor Musculoskeletal Dis. 2025;3:100782
This article belongs to the special issue Biosimilars: State of the Art in the Treatment of Rheumatic Diseases
Open Access
Short Communication
Patterns and inequities in pyogenic arthritis-related mortality in the United States from 1999–2020
Usama Qamar ... Eisha Mazhar
Published: January 27, 2025 Explor Musculoskeletal Dis. 2025;3:100781
Open Access
Review
Chronic pain, fibromyalgia, and long COVID
Jürgen Braun
Published: January 22, 2025 Explor Musculoskeletal Dis. 2025;3:100780
Journal Information